Real-time enrollment status for this neuroblastoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 4:21 AM UTC
| NCT Number | NCT05400603 |
| Recruiting Status | Recruiting |
| Condition | Neuroblastoma |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Emory University |
| Last Updated on CT.gov | December 26, 2025 (Dec 26, 2025) |
As of July 17, 2026: Clinical trial NCT05400603 is currently recruiting participants. This phase1 study for neuroblastoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Emory University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05400603 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05400603 was last updated Dec 26, 2025 (December 26, 2025). HelloStudys verifies this status automatically.